Monoclonal antibodies against amyloid beta protein and uses thereof

US10208109B2 · kind B2 · utility

Assignees

• Abb Vie Inc. · US
• Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

• Heinz Hillen · Herbrechtingen, DE
• Stefan Barghorn · Mannheim, DE
• Boris Labkovsky · Framingham, US
• Ulrich Ebert · Mannheim, DE
• Andreas Striebinger · Speyer, DE
• Patrick Keller · Darmstadt, DE

Key dates

• Filing date: Jul 21, 2011
• Grant date: Feb 19, 2019
• Expiry date: Feb 12, 2035

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2800/2821
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The subject invention relates to monoclonal antibodies (e.g., 8F5 and 8C5) that may be used, for example, in the prevention, treatment and diagnosis of Alzheimer's Disease or other neurodegenerative disorders.